Professional Documents
Culture Documents
Chapters 88 and 89 ANSWERS
Chapters 88 and 89 ANSWERS
2. A canine patient presents with a recent history of lip-smacking, hypersalivation and symmetric
bilateral non-painful mandibular swelling. What would be the most appropriate next
management option from this list?
a. Start trial treatment with glucocorticoids.
b. Perform bilateral mandibular sialoadenectomy.
c. Start trial treatment with phenobarbital. CORRECT
d. Perform incisional salivary gland biopsies.
3. According to the study by Hammer et al. (JAAHA 2001), what percentage of dogs and cats had
regional lymph node involvement at the time of diagnosis of salivary gland neoplasia?
a. 17% of cats and 39% of dogs.
b. 39% of cats and 17% of dogs. CORRECT
c. 16% of cats and 8% of dogs. THIS IS THE RATE OF DISTANT METASTASIS
d. 8% of cats and 16% of dogs.
4. Which approach was recommended should be considered in the study “Comparison of three
surgical approaches for zygomatic sialoadenectomy in canine cadavers” by Dorner et al.
(VetSurg 2021) as an alternative to the technique described on Tobias?
a. Ventral approach without zygomatic arch ostectomy. CORRECT
b. Lateral approach with zygomatic arch ostectomy. DESCRIBED ON TOBIAS
c. Dorsal approach without zygomatic arch ostectomy.
d. Ventral approach with zygomatic arch ostectomy.
5. Which vessel almost invariably must be ligated or cauterized and transected during
mandibulectomy, and where does it enter the mandibular bone?
a. Inferior alveolar artery. Mandibular foramen. CORRECT
b. Inferior alveolar artery. Alveolar foramen.
c. Right lingual artery. Mandibular foramen.
d. Mandibular artery. Alveolar foramen.
6. Select the correct answer regarding the most common oral tumors of dogs, in approximate
descending order of frequency:
a. Squamous cell carcinoma, fibrosarcoma, osteosarcoma, malignant melanoma, and
acanthomatous ameloblastoma.
b. Malignant melanoma, fibrosarcoma, osteosarcoma, squamous cell carcinoma, and
acanthomatous ameloblastoma.
c. Malignant melanoma, squamous cell carcinoma, fibrosarcoma, acanthomatous
ameloblastoma, and osteosarcoma.
d. Malignant melanoma, squamous cell carcinoma, fibrosarcoma, osteosarcoma, and
acanthomatous ameloblastoma. CORRECT